Clinical Trials Browser

Carcinoma, Hepatocellular × Vancomycin × Gastrointestinal × Clear all

NCT03785210 2026-02-23

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Phase 2 Terminated

22 enrolled 13 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05690048 2025-08-06

FLORA

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT04025567 2020-03-16

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular